Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03859492 · ClinicalTrials.gov registry record · NA
Screening CEDM in Intermediate and High-Risk Patient Populations
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 461
- Enrollment target
NCT03859492: Completed NA study, sponsored by Mayo Clinic.
NCT03859492 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 461 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03859492, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 461 participants
- Enrollment target
Study Summary
This research study is being done to determine if Contrast Enhanced Digital Mammography (CEDM) can improve breast cancer detection and can be used as an additional screening method to the standard mammographic screening.
Interventions
- DEVICE Contrast Enhanced Digital Mammography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 461 participants |
| Start Date | 2019-02-15 |
| Est. Completion | 2021-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03859492
The ClinicalTrials.gov registry entry for NCT03859492 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 461 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Contrast Enhanced Digital Mammography is the first listed.
NCT03859492 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03859492 about?
NCT03859492 is a clinical study titled "Screening CEDM in Intermediate and High-Risk Patient Populations". This research study is being done to determine if Contrast Enhanced Digital Mammography (CEDM) can improve breast cancer detection and can be used as an additional screening method to the standard mammographic screening.
What is the current status of trial NCT03859492?
This trial is currently completed. It is a NA study. The enrollment target is 461 participants. The study started on 2019-02-15. Estimated completion is 2021-05-31.
What interventions are being tested in trial NCT03859492?
The interventions under investigation include: Contrast Enhanced Digital Mammography (DEVICE).
Who is sponsoring clinical trial NCT03859492?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.